<DOC>
	<DOCNO>NCT02357472</DOCNO>
	<brief_summary>The supplementation Dehydroepiandrosterone ( DHEA ) use center patient previous poor ovarian reserve response attempt improve pregnancy outcome . However , still controversy clinical effect 75mg/d use , especially Asian people . Whether double dosage DHEA patient poor ovarian reserve response China improve IVF outcome little side effect unknown . The aim randomize control study compare effect high dose ( 150mg daily ) standard dose ( 75mg daily ) DHEA number oocyte obtain poor ovarian responder . The effect DHEA action cumulus cell examine .</brief_summary>
	<brief_title>The Effect Higher Dose Dehydroepiandrosterone ( DHEA ) Supplementation Poor Responders</brief_title>
	<detailed_description>Consecutive infertile woman attend subfertility clinic Shang Hai Ji Ai Genetics &amp; IVF Institute IVF treatment approach . Those fulfil selection criterion state would recruit write consent obtain detailed explanation counseling . Poor ovarian responder define accord Bologna criterion fulfil 2 3 following : ( ) Advanced maternal age ( &gt; /= 40 ) genetic acquire risk factor poor ovarian response ( POR ) ; ( ii ) Previous poor ovarian response ( POR ) ( &lt; /= 3 oocyte conventional stimulation protocol use least 150 international unit ( IU ) gonadotrophins per day ) ( iii ) Abnormal ovarian reserve test [ i.e . antral follicle count ( AFC ) &lt; 5-7 antimüllerian hormone ( AMH ) &lt; 0.5 - 1.1ng/ml ] Alternatively , two episode POR maximal stimulation sufficient define patient poor responder absence advance maternal age abnormal ovarian reserve test ( ORT ) . Baseline assessment perform early follicular phase ( Day 2 3 ) recruitment . Patient characteristic include age , Body Mass Index ( BMI ) , smoke status would record blood test include follicular stimulate hormone ( FSH ) , estradiol ( E2 ) , testosterone , DHEA-S , full blood count , renal liver function test would check . Pelvic scan perform assess total AFC total ovarian volume . Subjects randomize divide two group : 1 . Standard dose group : Subjects take DHEA ( Lab Hercules™ ) 25mg three time day 12 week prior start IVF treatment till day egg collection . 2 . High dose group : Subjects take DHEA ( Lab Hercules™ ) 50mg three time day 12 week prior start IVF treatment till day egg collection . Hormonal profile , ultrasound assessment , full blood count , renal liver function test repeat follicular phase ( D2 3 ) every month cycle follow IVF treatment use antagonist protocol base standard departmental regimen . The human menopausal gonadotropin ( hMG ) injection start 300 international unit ( IU ) 2 day follow 300 international unit ( IU ) daily . Improvement ovarian reserve marker would assess change serum AMH time recruitment 6 12 week DHEA . Cycle characteristic include dose gonadotrophin use , duration stimulation , number oocyte obtain , number fertilize embryos good quality embryo record follicular fluid save hormonal profile . Statistics 1 . Statistical test Statistical comparison perform accord intention treat principle Student test Fisher 's exact test normally distribute data Mann-Whitney test skew data . Chi-square test would use binary variable . Statistical analysis perform use Statistical Package ( ) Social Sciences ( SPSS ) software P-value 0.05 would consider statistically significant . Linear regression analysis / logistic regression analysis curve would use evaluate age , BMI , smoking , FSH , E2 , AMH , testosterone , DHEA-S , AFC , ovarian volume duration DHEA use prediction improve ovarian reserve DHEA supplementation . 2 . Sample size estimation The number oocytes retrieve used primary outcome study . Based database patient undergoing IVF treatment , mean oocyte obtain 2.7 standard deviation ( SD ) 1.4 . Assuming increase oocyte obtain 1.0 clinically significant , 18 subject arm would require achieve test significance 0.05 power 0.8 . Considering possible dropout , aim recruit 18 patient arm , i.e . 36 patient . In order compare one secondary outcome -- AMH ( relevance effect ovarian response ) adequate power , base database patient undergoing IVF treatment , mean AMH group poor ovarian reserve 0.8 SD 0.6 . Assuming increase number oocyte retrieve 0.5 clinically significant , 25 subject arm would require achieve test significance 0.01 power 0.9 . Totally 50 patient .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>1. age &lt; 45 year , 2. subfertility &gt; 1 year , 3 . A previous POR ( ≤3 oocytes conventional stimulation protocol least 150 IU FSH per day ) ; 4 . An abnormal ovarian reserve test ( i.e . AFC ≤57 follicle AMH ≤0.51.1 ng/ml ) . Patients exclude : 1. history ovarian cystectomy oophorectomy , 2. receive cytotoxic chemotherapy , 3. receive pelvic irradiation , 4. history take testosterone DHEA supplementation</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Reproductive aging</keyword>
	<keyword>DHEA</keyword>
	<keyword>poor ovarian responder</keyword>
</DOC>